Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma

BACKGROUND & AIM: In clinical practice, transarterial chemoembolization (TACE) has been widely used for the treatment of hepatocellular carcinoma (HCC) beyond as well as within guideline recommendations. Here we aimed to verify whether two consecutive non-responses could be an optimal criterion...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jonggi, Lee, Danbi, Shim, Ju Hyun, Kim, Kang Mo, Lim, Young-Suk, Lee, Yung Sang, Lee, Han Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055892/
https://www.ncbi.nlm.nih.gov/pubmed/32130270
http://dx.doi.org/10.1371/journal.pone.0229696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055892/
https://www.ncbi.nlm.nih.gov/pubmed/32130270
http://dx.doi.org/10.1371/journal.pone.0229696

Ejemplares similares